Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Urethral Stricture Companies

Urethral strictures are narrowings or blockages in the urethra, the tube that carries urine from the bladder to the outside of the body. Companies involved in the management of urethral strictures often provide medical devices, instruments, and treatment options for urologists and healthcare professionals.

Urethral Strictures Key Companies *Disclaimer: List of key companies in no particular orderLatest Urethral Companies Update

Sptember 2023: Laborie Medical Technologies Inc. further expanded its portfolio through a series of recent transactions, as seen by its latest agreement to purchase Urotronic Inc. The acquisition is valued at $255 million in upfront cash, with an additional $345 million to be paid based on the achievement of certain commercial and reimbursement objectives. Laborie had previously acquired a minority stake in the maker of the Optilume drug-coated balloon technology, which is utilized for the treatment of urethral strictures and benign prostatic hyperplasia (BPH).

February 2023: scPharmaceuticals Inc. (Nasdaq: SCPH) has recently made an announcement regarding the launch and commercial availability of FUROSCIX®, a unique formulation of furosemide that is administered through an on-body infusor. This product is intended for the outpatient treatment of congestion caused by fluid overload in adult patients who have New York Heart Association (NYHA) Class II and Class III chronic heart failure. The company's primary focus is on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs. The administration of FUROSCIX is contraindicated in emergency conditions and in individuals presenting with acute pulmonary edema. The administered dosage of the FUROSCIX Infusor is limited to 80 milligrams. Acute urinary retention can be induced in individuals experiencing significant symptoms of urinary retention, which may arise from bladder emptying issues, prostatic hyperplasia, or urethral constriction, as a result of furosemide treatment. This occurrence is attributed to the heightened production and retention of urine.

List of Urethral Key companies in the market

Stryker Corporation

StarmedtecGmbh

Cook Medical Incorporated

Jena Surgical GmbH

Boston Scientific Corporation

KgLumenis Ltd.

Richard Wolf Gmbh

Karl Storz GmbH & Co Healthtronics, Inc.

Olympus Corporation

Urethral Stricture Market Highlights:

Urethral Stricture Market Size

Urethral Stricture Market Trends

Urethral Stricture Market Analysis

Urethral Stricture Market Share

Urethral Stricture Market Highlights:

Urethral Stricture Market Trends

Urethral Stricture Market Analysis

Urethral Stricture Market Share

Urethral Stricture Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.